http://arrowsmith.psych.uic.edu/cgi-bin/arrowsmith_uic/edit_b.cgi Start A-Literature C-Literature B-list Filter Literature A-query: human papillomavirus types and cervical... C-query: virus-like particle vaccine The B-list contains title words and phrases (terms) that appeared in both the A and the C literature. 53 articles appeared in both literatures and were not included in the process of computing the B-list but can be viewed here . The results of this search are saved under id # 31660 and can be accessed from the start page after you leave this session. There are 72 terms on the current B-list ( 24 are predicted to be relevant), which is shown ranked according to predicted relevance. The list can be further trimmed down using the filters listed in the left margin. To assess whether there appears to be a biologically significant relationship between the AB and BC literatures for specific B-terms, please select one or more B-terms and then click the button to view the corresponding AB and BC literatures. Use Ctrl to select multiple B-terms. job id # 31660 started Tue Dec 28 03:27:22 2010 Max_citations: 50000 Stoplist: /var/www/html/arrowsmith_uic/data/stopwords_pubmed Ngram_max: 3 31660 Search ARROWSMITH A A_query_raw: human papillomavirus types and cervical cancerTue Dec 28 03:27:41 2010 A query = human papillomavirus types and cervical cancer started Tue Dec 28 03:27:42 2010 A query resulted in 2966 titles 31660 Search ARROWSMITH C C_query_raw: virus-like particle vaccine Tue Dec 28 03:28:34 2010 C: virus-like particle vaccine 398 A: pubmed_query_A 2966 AC: ( human papillomavirus types and cervical cancer ) AND ( virus-like particle vaccine ) 53 C query = virus-like particle vaccine started Tue Dec 28 03:28:36 2010 C query resulted in 398 titles A AND C query resulted in 53 titles 911 B-terms ready on Tue Dec 28 03:28:49 2010 Sem_filter: Genes Molecular Sequences, and Gene Protein Names 72 B-terms left after filter executed Tue Dec 28 03:31:21 2010 B-list on Tue Dec 28 03:32:01 2010 1 cin 2 e6 3 e7 4 major capsid protein 5 codon 6 capsid 7 ctl 8 hla 9 human papillomavirus gene 10 hiv 11 p27 12 l1 gene 13 l1 14 vlp 15 cd8 16 polymerase 17 cd4 18 ifn 19 l2 20 e2 21 genome 22 immune response 23 iga 24 ifn gamma 25 tgf beta1 26 ha 27 variant 28 fused 29 rna 30 igg 31 era 32 cytokine 33 domain 34 gene 35 impact 36 prep 37 low 38 constitutive 39 cell 40 co 41 novel 42 sex 43 protein 44 pilot 45 cycle 46 fusion 47 male 48 line 49 or 50 double 51 gamma 52 mice 53 block 54 phase 55 pre 56 term 57 receptor 58 ligand 59 alpha 60 skin 61 lethal 62 early 63 segment 64 group 65 non 66 activity 67 nine 68 membrane 69 a 70 beta 71 large 72 safe Start A-Literature C-Literature B-list Filter Literature AB literature B-term BC literature human papillomavirus types and... e6 virus-like particle vaccine 1: A prospective study on the natural course of low-grade squamous intraepithelial lesions and the presence of HPV16 E2-, E6- and E7-specific T-cell responses.2010 Add to clipboard 2: Alternative splicing of human papillomavirus type-16 E6/ E6* early mRNA is coupled to EGF signaling via Erk1/2 activation.2010 Add to clipboard 3: E6/ E7 mRNA expression analysis: a test for the objective assessment of cervical adenocarcinoma in clinical prognostic procedure.2010 Add to clipboard 4: Clinical Performance of PreTect HPV-Proofer E6/ E7 mRNA Assay in Comparison with Hybrid Capture 2 Test for the Detection of Women at Risk of Cervical Cancer.2010 Add to clipboard 5: The E2F5 repressor is an activator of E6/ E7 transcription and of the S-phase entry in HPV18-associated cells.2010 Add to clipboard 6: Triage of Women with Minor Cervical Lesions: Data Suggesting a Test and Treat Approach for HPV E6/ E7 mRNA Testing.2010 Add to clipboard 7: Degradation of p53 by Human Alphapapillomavirus E6 Proteins Shows a Stronger Correlation with Phylogeny than Oncogenicity.2010 Add to clipboard 8: APTIMA HPV E6/ E7 mRNA Test is As Sensitive As Hybrid Capture 2 Assay But More Specific At Detecting Cervical Precancer and Cancer.2010 Add to clipboard 9: E6 variants of human papillomavirus 18 differentially modulate the protein kinase B/phosphatidylinositol 3-kinase (akt/PI3K) signaling pathway.2009 Add to clipboard 10: A novel peptide motif binding to and blocking the intracellular activity of the human papillomavirus E6 oncoprotein.2009 Add to clipboard 11: E7 oncoprotein of novel human papillomavirus type 108 lacking the E6 gene induces dysplasia in organotypic keratinocyte cultures.2009 Add to clipboard 12: Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. 2009 Add to clipboard 13: Binding of PDZ proteins to HPV E6 proteins does neither correlate with epidemiological risk classification nor with the immortalization of foreskin keratinocytes.2009 Add to clipboard 14: Microarray analysis identifies differentially expressed genes induced by human papillomavirus type 18 E6 silencing RNA.2009 Add to clipboard 15: 2009 Add to clipboard 16: New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer.2008 Add to clipboard 17: Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India.2008 Add to clipboard 18: Predictive testing of early cervical pre-cancer by detecting human papillomavirus E6/ E7 mRNA in cervical cytologies up to high-grade squamous intraepithelial lesions: diagnostic and prognostic implications.2008 Add to clipboard 19: Human papillomavirus E6/ E7 mRNA testing as a predictive marker for cervical carcinoma.2008 Add to clipboard 20: The interaction between human papillomavirus type 16 and FADD is mediated by a novel E6 binding domain.2008 Add to clipboard 21: Isolation of RNA from residual BD SurePath liquid-based cytology specimens and detection of HPV E6/ E7 mRNA using the PreTectt HPV-Proofer assay.2008 Add to clipboard 22: Cellular distribution of tumour suppressor protein p53 and high-risk human papillomavirus (HPV)-18 E6 fusion protein in wild-type p53 cell lines.2008 Add to clipboard 23: HPV E6, E6AP and cervical cancer.2008 Add to clipboard 24: E6AP-dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein.2007 Add to clipboard 25: Human papillomavirus (HPV) types 101 and 103 isolated from cervicovaginal cells lack an E6 open reading frame (ORF) and are related to gamma-papillomaviruses.2007 Add to clipboard 26: High-risk HPV E6 oncoproteins assemble into large oligomers that allow localization of endogenous species in prototypic HPV-transformed cell lines.2007 Add to clipboard 27: PreTect HPV-Proofer: real-time detection and typing of E6/ E7 mRNA from carcinogenic human papillomaviruses.2007 Add to clipboard 28: Identification of HLA-DR1- and HLA-DR15-restricted human papillomavirus type 16 (HPV16) and HPV18 E6 epitopes recognized by CD4+ T cells from healthy young women.2007 Add to clipboard 29: Evaluation of different glutathione S-transferase-tagged protein captures for screening E6/ E6AP interaction inhibitors using AlphaScreen.2007 Add to clipboard 30: Suppression of cervical carcinoma cell growth by intracytoplasmic codelivery of anti-oncoprotein E6 antibody and small interfering RNA.2007 Add to clipboard 31: A new E6/ P63 pathway, together with a strong E7/E2F mitotic pathway, modulates the transcriptome in cervical cancer cells.2007 Add to clipboard 32: Identification of cellular targets for the human papillomavirus E6 and E7 oncogenes by RNA interference and transcriptome analyses.2007 Add to clipboard 33: Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins.2007 Add to clipboard 34: Intracellular scFvs against the viral E6 oncoprotein provoke apoptosis in human papillomavirus-positive cancer cells.2007 Add to clipboard 35: Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA.2006 Add to clipboard 36: Detection of human papillomavirus type 18 E6 and E7-specific CD4+ T-helper 1 immunity in relation to health versus disease.2006 Add to clipboard 37: Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoprotein.2006 Add to clipboard 38: Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas.2006 Add to clipboard 39: Oncogenic human papillomavirus (HPV) type distribution and HPV type 16 E6 variants in two Spanish population groups with different levels of HPV infection risk.2006 Add to clipboard 40: Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner.2006 Add to clipboard 41: Recognition of a cervical cancer derived tumor cell line by a human papillomavirus type 16 E6 52-61-specific CD8 T cell clone.2006 Add to clipboard 42: Expression of E6/ E7 mRNA from 'high risk' human papillomavirus in relation to CIN grade, viral load and p16INK4a.2006 Add to clipboard 43: The prevalence of HPV-18 and variants of E6 gene isolated from cervical cancer patients in Taiwan.2005 Add to clipboard 44: Kinetic analysis of the interactions of human papillomavirus E6 oncoproteins with the ubiquitin ligase E6AP using surface plasmon resonance.2005 Add to clipboard 45: Differential splicing of E6 within human papillomavirus type 18 variants and functional consequences.2005 Add to clipboard 46: Decreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human papillomavirus type 16 E6/ E7 is related to reduced macrophage inflammatory protein-3alpha production.2005 Add to clipboard 47: Increased incidence of squamous cell carcinomas in Mastomys natalensis papillomavirus E6 transgenic mice during two-stage skin carcinogenesis.2004 Add to clipboard 48: Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from human papillomaviruses types 5 and 18.2004 Add to clipboard 49: Generation of a DNA microarray for determination of E6 natural variants of human papillomavirus type 16.2004 Add to clipboard 50: Ubiquitination and proteasome degradation of the E6 proteins of human papillomavirus types 11 and 18.2004 Add to clipboard 51: HPV-18 E6* I modulates HPV-18 full-length E6 functions in a cell cycle dependent manner.2004 Add to clipboard 52: Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction.2004 Add to clipboard 53: G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value.2003 Add to clipboard 54: Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer.2003 Add to clipboard 55: Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease.2002 Add to clipboard 56: Analysis of E6 variants of human papillomavirus type 33, 52 and 58 in Japanese women with cervical intraepithelial neoplasia/cervical cancer in relation to their oncogenic potential.2001 Add to clipboard 57: Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA.2001 Add to clipboard 58: Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia.2000 Add to clipboard 59: Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis.2000 Add to clipboard 60: Repression of the integrated papillomavirus E6/ E7 promoter is required for growth suppression of cervical cancer cells.2000 Add to clipboard 61: Analysis of mutations in the URR and E6/ E7 oncogenes of HPV 16 cervical cancer isolates from central China.2000 Add to clipboard 62: Human papillomavirus type 16 E6/ E7-specific cytotoxic T lymphocytes in women with cervical neoplasia.2000 Add to clipboard 63: Ubiquitous presence of E6 and E7 transcripts in human papillomavirus-positive cervical carcinomas regardless of its type.2000 Add to clipboard 64: Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.2000 Add to clipboard 65: Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7.2000 Add to clipboard 66: Differences in HPV 16- and HPV 18 E6/ E7 oncogene expression between in situ and invasive adenocarcinomas of the cervix uteri.2000 Add to clipboard 67: Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines.1999 Add to clipboard 68: Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells.1999 Add to clipboard 69: Inhibition of HPV-16 E6/ E7 immortalization of normal keratinocytes by hairpin ribozymes.1998 Add to clipboard 70: DNA-EIA to detect high and low risk HPV genotypes in cervical lesions with E6/ E7 primer mediated multiplex PCR.1998 Add to clipboard 71: High-risk human papillomavirus infection and E6 protein expression in lesions of the uterine cervix.1998 Add to clipboard 72: The papillomavirus E6 proteins.1998 Add to clipboard 73: HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.1998 Add to clipboard 74: Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth.1997 Add to clipboard 75: Genomic instability and telomerase activity in human bronchial epithelial cells during immortalization by human papillomavirus-16 E6 and E7 genes.1997 Add to clipboard 76: A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.1996 Add to clipboard 77: Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: repression of E6/ E7-oncogene expression and induction of apoptosis.1996 Add to clipboard 78: Mechanism of HPV E6 proteins in cellular transformation.1996 Add to clipboard 79: Functional consequences of directed mutations in human papillomavirus E6 proteins: abrogation of p53-mediated cell cycle arrest correlates with p53 binding and degradation in vitro.1995 Add to clipboard 80: Scanning the structure and antigenicity of HPV-16 E6 and E7 oncoproteins using antipeptide antibodies.1994 Add to clipboard 81: Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.1993 Add to clipboard 82: Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53.1993 Add to clipboard 83: Comparison of L1 consensus primers with E6 type specific primers for detection of human papillomaviruses in paraffin sections of cervical neoplasia.1993 Add to clipboard 84: Characterization of HPV-16 E6/ E7 transcription in CaSki cells by quantitative PCR.1992 Add to clipboard 85: The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture.1991 Add to clipboard 86: Tumorigenicity of the E6 and E6- E7 gene constructions derived from human papillomavirus type 33.1991 Add to clipboard 87: In vitro biological activities of the E6 and E7 genes vary among human papillomaviruses of different oncogenic potential.1991 Add to clipboard 88: Mapping of linear epitopes of human papillomavirus type 16: the E1, E2, E4, E5, E6 and E7 open reading frames.1990 Add to clipboard 89: 1990 Add to clipboard 90: HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.1989 Add to clipboard 91: 1988 Add to clipboard 92: Identification of the human papillomavirus type 18 E6 and E6 proteins in nuclear protein fractions from human cervical carcinoma cells grown in the nude mouse or in vitro.1988 Add to clipboard 93: Conservation of E6 and E7 regions of human papillomavirus types 16 and 18 present in cervical cancers.1987 Add to clipboard 1: Construction and characterization of recombinant fowlpox viruses expressing human papilloma virus E6 and E7 oncoproteins.2009 Add to clipboard
http://www.gopubmed.org/web/gopubmed/1?WEB019jnt856e3gq0IgI1I00f01000j10040001rl Human Papillomavirus and Cervical Cancer 10,158 documents semantically analyzed 1 2 Top Years Publications 2008 935 2007 907 2009 848 2006 753 2005 644 2003 555 2004 503 2002 459 2001 429 2000 422 1999 351 1992 319 1996 317 1997 291 1998 286 1995 274 1993 272 1994 269 1991 257 1990 218 1 2 1 2 3 ... 6 Top Countries Publications USA 2,703 United Kingdom 615 Germany 471 China 434 Japan 415 Italy 386 France 354 Netherlands 297 Canada 237 Sweden 201 South Korea 188 Brazil 188 India 169 Taiwan 168 Australia 167 Mexico 151 Finland 139 Spain 132 Belgium 111 Denmark 80 1 2 3 ... 6 1 2 3 ... 40 Top Cities Publications Bethesda 265 London 220 Heidelberg 175 New York 166 Boston 148 Baltimore 131 Amsterdam 129 Seoul 126 Seattle 115 Rome 110 Taipei 105 Beijing 99 Lyon 96 Mexico City 96 San Francisco 96 Paris 96 Tokyo 94 Houston 92 Montreal 88 Laizhou 85 1 2 3 ... 40 1 2 3 ... 67 Top Journals Publications Gynecol Oncol 420 Int J Cancer 395 Cancer 206 Vaccine 160 J Virol 158 Cancer Res 158 Eur J Gynaecol Oncol 153 Brit J Cancer 147 Cancer Epidem Biomar 141 J Med Virol 140 Obstet Gynecol 132 Int J Gynecol Cancer 129 Am J Obstet Gynecol 127 Lancet 126 Virology 108 Int J Gynecol Pathol 105 J Clin Pathol 103 J Clin Microbiol 99 J Gen Virol 98 J Infect Dis 93 1 2 3 ... 67 1 2 3 ... 460 Top Terms Publications Humans 9,645 Uterine Cervicitis 8,680 Uterine Cervical Neoplasms 8,328 Papillomaviridae 6,876 Papillomavirus Infections 5,846 Women 4,115 Adult 3,906 Tumor Virus Infections 3,251 Cervical Intraepithelial Neoplasia 3,231 Viruses 3,169 DNA 3,163 Carcinoma 2,927 DNA, Viral 2,920 Middle Aged 2,811 Human papillomavirus 16 2,752 Patients 2,738 Polymerase Chain Reaction 2,228 Vaginal Smears 2,145 Cervix Uteri 2,081 cervix development 2,056 1 2 3 ... 460 1 2 3 ... 1427 Top Authors Publications Meijer C 179 Schiffman M 159 Syrjnen K 111 Burk R 107 Snijders P 106 Shah K 101 Munoz N 100 Franco E 99 Bosch F 97 Herrero R 90 Sherman M 89 Crum C 86 Lorincz A 83 Dillner J 83 Walboomers J 83 Hildesheim A 82 Syrjnen S 78 Castle P 73 Villa L 68 Wright T 65 1 2 3 ... 1427 http://www.sciencenet.cn/htmlpaper/200912111335296327994.shtm 宫颈癌风险HPV DNA检测优于细胞学检测 最新出版的《美国流行病学杂志》( AJE )发表的一项来自中国的研究表明,人乳头状瘤病毒(HPV)DNA检测对子宫颈高度癌前病变(CIN2+)发病风险的预测效果优于细胞学检测。该研究由中国医学科学院、北京协和医学院肿瘤研究所教授乔友林带领的团队完成。 为了评价基线HPV和细胞学状态与子宫颈癌前病变发生发展的关联强度,乔友林等于2005年底对参加过1999年山西子宫颈癌筛查研究的妇女进行追踪随访。1999年在山西农村完成的该基线研究共招募了1997名妇女参加。2005年底,共有1612名基线确诊为组织学正常或低度癌前病变的妇女被召回,随访研究使用的筛查技术包括子宫颈肉眼观察、液基细胞学检查和HPV DNA检测。研究人员认为,基线HPV检测对6年后CIN2+的敏感度和特异度分别是90.0%和86.2%,而细胞学检测则分别是60.0%和78.6%。乔友林认为,如果30岁及以上妇女能够得到终生至少一次的HPV DNA筛查,并在病变筛出后得到恰当治疗,那么子宫颈癌死亡率预计可以很快下降一半或1/3。 careHPV技术因其快速、简便、价廉、适合在落后地区使用的特点,在实现子宫颈癌的快速准确筛查方面将极具应用前景。结合careHPV研究取得的数据,研究人员认为,将HPV检测作为独立的初筛手段将会很有吸引力,尤其是对于那些负担不起细胞学筛查项目的国家和地区。(来源:科学时报 潘锋) 更多阅读 《美国流行病学杂志》发表论文摘要(英文) American Journal of Epidemiology Advance Access originally published on lin e on August 19, 2009 American Journal of Epidemiology 2009 170(6):708-716; doi:10.1093/aje/kwp188 American Journal of Epidemiology The Author 2009. Published by the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org. ORIGINAL CONTRIBUTIONS Human Papillomavirus Testing for Cervical Cancer Screening: Results From a 6-Year Prospective Study in Rural China Ju-Fang Shi , Jerome L. Be lin son , Fang-Hui Zhao , Robert G. Pretorius , Jing Li , Jun-Fei Ma , Feng Chen , Wang Xiang , Qin-Jing Pan , Xun Zhang , Wen-Hua Zhang , You - Lin Qiao and Jennifer S. Smith Correspondence to Prof. You - Lin Qiao, Department of Cancer Epidemiology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, 17 South Panjiayuan Lane, Chaoyang District, Beijing 100021, People's Republic of China (e-mail: qiaoy@cicams.ac.cn